Policy paper

Cannabis-based medicines expert panel: privacy impact notice

How civil servants manage personal data on behalf of the expert panel who assess applications for special licences to prescribe cannabis-based medicines.

• From: Home Office
• Published: 27 June 2018

This publication was withdrawn on 26 July 2019

Cannabis-based medicines expert panel no longer exists.

Documents

Expert panel privacy impact notice

PDF, 325 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This privacy impact notice is provided in accordance with data protection legislation. It sets out how statutory obligations relating to the management of personal data will be addressed, on behalf of the expert panel, by the civil servants that support the expert panel in the Home Office Science Secretariat.

The notice incorporates the General Data Protection Regulations (GDPR) and has been created following the guidance issued by the Information Commissioner’s Office and in consideration of the privacy and data protection policy for the expert panel guidance.

The contact details for the Home Office Data Protection Officer

Email: dpo@homeoffice.gov.uk

Postal address:

Office of the DPO
Peel Building
2 Marsham Street
London
SW1P 4DF

Telephone number: 020 7035 6999

You have the right to complain to the Information Commissioner’s Office about the way the ASC is handling your personal information. You can contact the ICO on 0303 123 1113 or via the ICO website.

Alternatively, you can write to the ICO at:

The Information Commissioner's Office
Wycliffe House
Water Lane
Wilmslow Cheshire
SK9 5AF

Published 27 June 2018